MarketInOut Stock Screener Log In | Sign Up
 

Lantheus Holdings Inc

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 05/12/2026 16:00
Lantheus Holdings Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization6,058.77 mln
Float58.22 mln
Earnings Date07/30/2026

EPS

4.19
Solid

P / E

22.97
Premium valuation

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.33
Borderline

1-Year Forecast

102
Modest upside

Relative Strength

91 / 100
Top performer

Business Description

Lantheus Holdings is a medical imaging and therapeutic company that develops and sells a broad range of products to help doctors detect and treat heart disease, cancer, and other conditions around the world. Its portfolio includes injectable agents for ultrasound and nuclear imaging, AI-powered software tools for assessing prostate cancer and Alzheimer's disease, and radiopharmaceutical therapies targeting advanced cancers. The company also has a growing pipeline of new diagnostic and treatment candidates developed in partnership with organizations such as GE Healthcare and Regeneron. Founded in 1956 and headquartered in Bedford, Massachusetts, Lantheus serves clinicians across multiple medical specialties.

Key Fundamentals

EPS4.19
P/E22.97
ROE24.25
RPS22.89
ROIC15.46
ROA12.66
Interest Cover14.64
EBITDA, mln473
EV / EBITDA13.09
EV / EBIT15.72
Revenue, mln1,546
EV / Revenue4.00

Financial Strength

Altman Z-Score5.2
Piotroski F-Score 5 / 9
Beneish M-Score-2.33
Price to Intrinsic Value1.35
Price to Graham Number4.15
1-Year Target Price102
Shiller PE Ratio44.32
Short Ratio5.85
Short % of Float10.44

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 12.13% 93 / 100   
1 Month 17.83% 86 / 100   
2 Months 45.8% 94 / 100   
6 Months 88.43% 96 / 100   
1 Year 17.73% 58 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us